Targeting angiogenesis versus myogenesis with cardiac cell therapy

References

• Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev.85, 1373–1416 (2005).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest.115, 572–583 (2005).
   PubMed Web of Science ®Google Scholar
• Simons M. Angiogenesis: where do we stand now? Circulation111, 1556–1566 (2005).
   PubMed Web of Science ®Google Scholar
• Roe MT, Ohman EM, Maas AC et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J. Am. Coll. Cardiol.37, 9–18 (2001).
   PubMed Web of Science ®Google Scholar
• Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation97, 765–772 (1998).
   PubMed Web of Science ®Google Scholar
• Hombach V, Grebe O, Merkle N et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur. Heart J.26, 549–557 (2005).
   PubMed Web of Science ®Google Scholar
• Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation109, 2080–2085 (2004).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275, 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Caplice NM, Doyle B. Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. Stem Cells Dev.14, 122–139 (2005).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation103, 634–637 (2001).
   PubMed Web of Science ®Google Scholar
• Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation104, 1046–1052 (2001).
   PubMed Web of Science ®Google Scholar
• Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med.7, 430–436 (2001).
   PubMed Web of Science ®Google Scholar
• Fuchs S, Baffour R, Zhou YF et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol.37, 1726–1732 (2001).
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Tkebuchava T, Yamaguchi J et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation107, 461–468 (2003).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell114, 763–776 (2003).
   PubMed Web of Science ®Google Scholar
• Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Capasso JM. Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart. J. Clin. Invest.85, 994–997 (1990).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Torella D, Sheikh F et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl Acad. Sci. USA102, 8692–8697 (2005).
   PubMed Web of Science ®Google Scholar
• Beltrami CA, Finato N, Rocco M et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation89, 151–163 (1994).
   PubMed Web of Science ®Google Scholar
• Braz JC, Gregory K, Pathak A et al. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med.10, 248–254 (2004).
   PubMed Web of Science ®Google Scholar
• Chimenti C, Kajstura J, Torella D et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res.93, 604–613 (2003).
   PubMed Web of Science ®Google Scholar
• Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ. Res.83, 1–14 (1998).
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med.344, 1750–1757 (2001).
   PubMed Web of Science ®Google Scholar
• Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl Acad. Sci. USA95, 8801–8805 (1998).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Quaini F, Tasca G et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl Acad. Sci. USA100, 10440–10445 (2003).
   PubMed Web of Science ®Google Scholar
• Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med.346, 5–15 (2002).
   PubMed Web of Science ®Google Scholar
• Muller P, Pfeiffer P, Koglin J et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation106, 31–35 (2002).
   PubMed Web of Science ®Google Scholar
• Thiele J, Varus E, Wickenhauser C et al. Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation77, 1902–1905 (2004).
   PubMed Web of Science ®Google Scholar
• Thiele J, Varus E, Wickenhauser C, Kvasnicka HM, Metz KA, Beelen DW. Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation. Histol. Histopathol.19, 201–209 (2004).
   PubMed Web of Science ®Google Scholar
• Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation106, 17–19 (2002).
   PubMed Web of Science ®Google Scholar
• Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation107, 1247–1249 (2003).
   PubMed Web of Science ®Google Scholar
• Taylor DA, Hruban R, Rodriguez ER, Goldschmidt-Clermont PJ. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation106, 2–4 (2002).
   PubMedGoogle Scholar
• Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol.22, 1282–1289 (2004).
   PubMed Web of Science ®Google Scholar
• Min JY, Yang Y, Converso KL et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol.92, 288–296 (2002).
   PubMed Web of Science ®Google Scholar
• Min JY, Yang Y, Sullivan MF et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J. Thorac. Cardiovasc. Surg.125, 361–369 (2003).
   PubMed Web of Science ®Google Scholar
• Yuasa S, Itabashi Y, Koshimizu U et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol.23, 607–611 (2005).
   PubMed Web of Science ®Google Scholar
• Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest.108, 407–414 (2001).
   PubMed Web of Science ®Google Scholar
• Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation108, 2070–2073 (2003).
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature410, 701–705 (2001).
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature428, 668–673 (2004).
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature428, 664–668 (2004).
   PubMed Web of Science ®Google Scholar
• Chien KR. Stem cells: lost in translation. Nature428, 607–608 (2004).
   PubMed Web of Science ®Google Scholar
• Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med.9, 1195–1201 (2003).
   PubMed Web of Science ®Google Scholar
• Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg.73, 1919–1925 (2002).
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res.95, 9–20 (2004).
   PubMed Web of Science ®Google Scholar
• Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res.95, 911–921 (2004).
   PubMed Web of Science ®Google Scholar
• Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA100, 12313–12318 (2003).
   PubMed Web of Science ®Google Scholar
• Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med.342, 626–633 (2000).
   PubMed Web of Science ®Google Scholar
• Badorff C, Brandes RP, Popp R et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation107, 1024–1032 (2003).
   PubMed Web of Science ®Google Scholar
• Kajstura J, Rota M, Whang B et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res.96, 127–137 (2005).
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation106, 1913–1918 (2002).
   PubMed Web of Science ®Google Scholar
• Assmus B, Schachinger V, Teupe C et al. Transplantation Of Progenitor Cells And Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation106, 3009–3017 (2002).
   PubMed Web of Science ®Google Scholar
• Schachinger V, Assmus B, Britten MB et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol.44, 1690–1699 (2004).
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet364, 141–148 (2004).
   PubMed Web of Science ®Google Scholar
• Britten MB, Abolmaali ND, Assmus B et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation108, 2212–2218 (2003).
   PubMed Web of Science ®Google Scholar
• Fernandez-Aviles F, San Roman JA, Garcia-Frade J et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res.95, 742–748 (2004).
   PubMed Web of Science ®Google Scholar
• Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol.94, 92–95 (2004).
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet367, 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Penn MS. Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk. Lancet367, 87–88 (2006).
   PubMed Web of Science ®Google Scholar
• Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ. Res.96, 151–163 (2005).
   PubMed Web of Science ®Google Scholar
• Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet363, 751–756 (2004).
   PubMed Web of Science ®Google Scholar
• Ince H, Petzsch M, Kleine HD et al. Preservation from left ventricular remodeling by Front-Integrated Revascularization and STem cell Liberation IN Evolving Acute Myocardial Infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation112, 3097–3106 (2005).
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation107, 2294–2302 (2003).
   PubMed Web of Science ®Google Scholar
• Hamano K, Nishida M, Hirata K et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ. J.65, 845–847 (2001).
   PubMedGoogle Scholar
• Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet361, 47–49 (2003).
   PubMed Web of Science ®Google Scholar
• Fuchs S, Satler LF, Kornowski R et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J. Am. Coll. Cardiol.41, 1721–1724 (2003).
   PubMed Web of Science ®Google Scholar
• Hill JM, Syed MA, Arai AE et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol.46, 1643–1648 (2005).
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J. Am. Coll. Cardiol.46, 1651–1658 (2005).
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Lehmann R et al. Transcoronary transplantation of progenitor cells and recovery of left ventricular function in patients with chronic ischemic heart disease: results of a randomized controlled trial. Circulation110, 238 (2004).
   Google Scholar
• Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet361, 45–46 (2003).
   PubMed Web of Science ®Google Scholar
• Stamm C, Kleine HD, Westphal B et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac. Cardiovasc. Surg.52, 152–158 (2004).
   PubMed Web of Science ®Google Scholar
• Menasche P, Hagege AA, Vilquin JT et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol.41, 1078–1083 (2003).
   PubMed Web of Science ®Google Scholar
• Herreros J, Prosper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J.24, 2012–2020 (2003).
   PubMed Web of Science ®Google Scholar
• Siminiak T, Kalawski R, Fiszer D et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am. Heart J.148, 531–537 (2004).
   PubMed Web of Science ®Google Scholar
• Smits PC, van Geuns RJ, Poldermans D et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol.42, 2063–2069 (2003).
   PubMed Web of Science ®Google Scholar
• Menasche P. Cellular transplantation: hurdles remaining before widespread clinical use. Curr. Opin Cardiol.19, 154–161 (2004).
   PubMed Web of Science ®Google Scholar
• Simper D, Wang S, Deb A et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation108, 143–149 (2003).
   PubMed Web of Science ®Google Scholar
• Caplice NM, Gersh BJ, Alegria JR. Cell therapy for cardiovascular disease: what cells, what diseases and for whom? Nat. Clin. Pract. Cardiovasc. Med.2, 37–43 (2005).
   PubMedGoogle Scholar
• Ziegelhoeffer T, Fernandez B, Kostin S et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res.94, 230–238 (2004).
   PubMed Web of Science ®Google Scholar
• Urbich C, Aicher A, Heeschen C et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell Cardiol.39, 733–742 (2005).
   PubMed Web of Science ®Google Scholar
• Li Q, Li B, Wang X et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest.100, 1991–1999 (1997).
   PubMed Web of Science ®Google Scholar
• Urbanek K, Rota M, Cascapera S et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res.97, 663–673 (2005).
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Liang OD et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med.11, 367–368 (2005).
   PubMed Web of Science ®Google Scholar
• Conti E, Andreotti F, Sciahbasi A et al. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J. Am. Coll. Cardiol.38, 26–32 (2001).
   PubMed Web of Science ®Google Scholar
• Lee WL, Chen JW, Ting CT, Lin SJ, Wang PH. Changes of the insulin-like growth factor I system during acute myocardial infarction: implications on left ventricular remodeling. J. Clin. Endocrinol. Metab.84, 1575–1581 (1999).
   PubMed Web of Science ®Google Scholar
• Gibbons RJ, Araoz PA. The year in cardiac imaging. J. Am. Coll. Cardiol.46, 542–551 (2005).
   PubMed Web of Science ®Google Scholar
• Meoli DF, Sadeghi MM, Krassilnikova S et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J. Clin. Invest.113, 1684–1691 (2004).
   PubMed Web of Science ®Google Scholar
• Lu E, Wagner WR, Schellenberger U et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation108, 97–103 (2003).
   PubMedGoogle Scholar
• Hofmann M, Wollert KC, Meyer GP et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation111, 2198–2202 (2005).
   PubMed Web of Science ®Google Scholar
• Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed.17, 484–499 (2004).
   PubMed Web of Science ®Google Scholar